Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7723055 | 0.77 | TP53 (0.55) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL6066163 | 0.75 | TP53 (0.53) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL7728256 | 0.75 | TP53 (0.53) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL28167487 | 0.74 | TP53 (0.51) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL27383021 | 0.69 | TP53 (0.53) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL19034100 | 0.69 | TP53 (0.51) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL30575200 | 0.67 | TP53 (0.45) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL28949251 | 0.65 | TP53 (0.49) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL471872 | 0.65 | TP53 (0.49) | TP53CYP3A4ALDH1A1 | |
| SCHEMBL124728 | 0.65 | TP53 (1.00) | TP53CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007516-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | SPEYSIDE MEDICAL LLC | 2026-01-08 | — | — | US | disclosed |
| US-12403007-B2 | Prosthetic implant delivery device with introducer catheter | SPEYSIDE MEDICAL LLC (US) | 2025-09-02 | — | — | US | disclosed |
| US-20230320855-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | SPEYSIDE MEDICAL LLC | 2023-10-12 | — | — | US | disclosed |
| US-20220265424-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | SPEYSIDE MEDICAL LLC (US) | 2022-08-25 | — | — | US | disclosed |
| US-20200281718-A1 | LOW CROSSING PROFILE DELIVERY CATHETER FOR CARDIOVASCULAR PROSTHETIC IMPLANT | SPEYSIDE MEDICAL LLC | 2020-09-10 | — | — | US | disclosed |
| US-10478299-B2 | Low crossing profile delivery catheter for cardiovascular prosthetic implant | DFM, LLC (US) | 2019-11-19 | — | — | US | disclosed |
| US-20170290660-A1 | LOW CROSSING PROFILE DELIVERY CATHETER FOR CARDIOVASCULAR PROSTHETIC IMPLANT | SPEYSIDE MEDICAL LLC | 2017-10-12 | — | — | US | disclosed |
| EP-3179959-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE | DFM, LLC (US) | 2017-06-21 | — | — | EP | disclosed |
| US-20170156857-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | SPEYSIDE MEDICAL LLC | 2017-06-08 | — | — | US | disclosed |
| US-9603708-B2 | Low crossing profile delivery catheter for cardiovascular prosthetic implant | DFM, LLC (US) | 2017-03-28 | — | — | US | disclosed |
| US-9445897-B2 | Prosthetic implant delivery device with introducer catheter | DIRECT FLOW MEDICAL, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160045311-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE | DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC | 2016-02-18 | — | — | US | disclosed |
| WO-2016025733-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE | DIRECT FLOW MEDICAL, INC. (US) | 2016-02-18 | — | — | WO | disclosed |
| EP-2844191-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | Direct Flow Medical, Inc. (US) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013165896-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | DIRECT FLOW MEDICAL, INC. (US) | 2013-11-07 | — | — | WO | disclosed |
| US-20130297010-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | SPEYSIDE MEDICAL LLC | 2013-11-07 | — | — | US | disclosed |
| EP-2571556-A2 | LOW CROSSING PROFILE DELIVERY CATHETER FOR CARDIOVASCULAR PROSTHETIC IMPLANT | Direct Flow Medical, Inc. (US) | 2013-03-27 | — | — | EP | disclosed |
| US-20120016468-A1 | LOW CROSSING PROFILE DELIVERY CATHETER FOR CARDIOVASCULAR PROSTHETIC IMPLANT | DIRECT FLOW MEDICAL, INC. (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2011146745-A2 | LOW CROSSING PROFILE DELIVERY CATHETER FOR CARDIOVASCULAR PROSTHETIC IMPLANT | DIRECT FLOW MEDICAL. INC. (US) | 2011-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007516-A1 | PROSTHETIC IMPLANT DELIVERY DEVICE WITH INTRODUCER CATHETER | F9, F8, EED | TP53 4116/4885CYP3A4 2077/4885ALDH1A1 4164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.